Opportunities for nanomaterials in enzyme therapy DOI Creative Commons
Beatriz Torres-Herrero, Ilaria Armenia,

Cecilia Ortiz

и другие.

Journal of Controlled Release, Год журнала: 2024, Номер 372, С. 619 - 647

Опубликована: Июнь 29, 2024

In recent years, enzyme therapy strategies have rapidly evolved to catalyze essential biochemical reactions with therapeutic potential. These approaches hold particular promise in addressing rare genetic disorders, cancer treatment, neurodegenerative conditions, wound healing, inflammation management, and infectious disease control, among others. There are several primary reasons for the utilization of enzymes as therapeutics: their substrate specificity, biological compatibility, ability generate a high number product molecules per unit. features encouraged application replacement where serves agent rectify abnormal metabolic physiological processes, prodrug initiates clinical effect by activating prodrugs, dynamic or starving acts upon host molecules. Currently, there >20 commercialized products based on enzymes, but approval rates considerably lower than other biologicals. This has stimulated nanobiotechnology last years develop nanoparticle-based solutions that integrate enzymes. approach aims enhance stability, prevent rapid clearance, reduce immunogenicity, even enable spatio-temporal activation catalyst. comprehensive review delves into emerging trends emphasis synergistic opportunities presented incorporating nanomaterials. Such integration holds enhancing existing therapies paving way innovative nanotherapeutic approaches.

Язык: Английский

RNA modifications in physiology and disease: towards clinical applications DOI Open Access
Sylvain Delaunay, Mark Helm, Michaela Frye

и другие.

Nature Reviews Genetics, Год журнала: 2023, Номер 25(2), С. 104 - 122

Опубликована: Сен. 15, 2023

Язык: Английский

Процитировано

126

Amino Acid Metabolism in Cancer Drug Resistance DOI Creative Commons

Hee-Chan Yoo,

Jung Min Han

Cells, Год журнала: 2022, Номер 11(1), С. 140 - 140

Опубликована: Янв. 2, 2022

Despite the numerous investigations on resistance mechanisms, drug in cancer therapies still limits favorable outcomes patients. The complexities of inherent characteristics tumors, such as tumor heterogeneity and complicated interaction within microenvironment, hinder efforts to overcome cells, requiring innovative approaches. In this review, we describe recent studies offering evidence for essential roles amino acid metabolism driving cells. Amino acids support cells counteracting by maintaining redox homeostasis, sustaining biosynthetic processes, regulating epigenetic modification, providing metabolic intermediates energy generation. addition, impacts anticancer immune responses, creating an immunosuppressive or immunoeffective microenvironment. A comprehensive understanding it relates therapeutic mechanisms will improve strategies.

Язык: Английский

Процитировано

73

Multifunctional nanomedicines-enabled chemodynamic-synergized multimodal tumor therapy via Fenton and Fenton-like reactions DOI Creative Commons
Haiyan Gao,

Zhiping Cao,

Huanhuan Liu

и другие.

Theranostics, Год журнала: 2023, Номер 13(6), С. 1974 - 2014

Опубликована: Янв. 1, 2023

Chemodynamic therapy (CDT) is well-known for using the tumor microenvironment to activate Fenton reaction or Fenton-like generate strong oxidative hydroxyl radicals tumor-specific treatment. It highly selective and safe, without depth limitation of tissue penetration, shows its potential as a new green therapeutic method with great clinical application. However, catalytic efficiency reagents involved in severely affected by inherent microenvironmental limitations tumors strict reaction-dependent conditions. With increasing application nanotechnology medical field, combined therapies based on different types functional nanomaterials have opened up avenues development next-generation CDT-enhanced system. This review will comprehensively exemplify representative results CDT other antitumor such chemotherapy, phototherapy, sonodynamic therapy, radiation magnetic hyperthermia immunotherapy, starvation gas gene oncosis combination thereof improving from hundreds latest literature, introduce strategies ingenious design nanomedicines regulations enhance further summarize challenges future perspective CDT-based multimodal anticancer therapy.

Язык: Английский

Процитировано

64

Amino acid metabolism in tumor biology and therapy DOI Creative Commons
Jie Chen,

Likun Cui,

Shaoteng Lu

и другие.

Cell Death and Disease, Год журнала: 2024, Номер 15(1)

Опубликована: Янв. 13, 2024

Abstract Amino acid metabolism plays important roles in tumor biology and therapy. Accumulating evidence has shown that amino acids contribute to tumorigenesis immunity by acting as nutrients, signaling molecules, could also regulate gene transcription epigenetic modification. Therefore, targeting will provide new ideas for treatment become an therapeutic approach after surgery, radiotherapy, chemotherapy. In this review, we systematically summarize the recent progress of malignancy their interaction with signal pathways well effect on microenvironment Collectively, highlight potential application future expectation.

Язык: Английский

Процитировано

64

Altered metabolism in cancer: insights into energy pathways and therapeutic targets DOI Creative Commons
Muhammad Tufail, Canhua Jiang, Ning Li

и другие.

Molecular Cancer, Год журнала: 2024, Номер 23(1)

Опубликована: Сен. 18, 2024

Язык: Английский

Процитировано

62

Recent developments on other platinum metal complexes as target-specific anticancer therapeutics DOI

Thimma Subramanian Prathima,

Badruzzaman Choudhury,

Md Gulzar Ahmad

и другие.

Coordination Chemistry Reviews, Год журнала: 2023, Номер 490, С. 215231 - 215231

Опубликована: Май 19, 2023

Язык: Английский

Процитировано

44

The roles of KRAS in cancer metabolism, tumor microenvironment and clinical therapy DOI Creative Commons

Qinglong Ma,

Wenyang Zhang, Kongming Wu

и другие.

Molecular Cancer, Год журнала: 2025, Номер 24(1)

Опубликована: Янв. 13, 2025

Abstract KRAS is one of the most mutated genes, driving alternations in metabolic pathways that include enhanced nutrient uptaking, increased glycolysis, elevated glutaminolysis, and heightened synthesis fatty acids nucleotides. However, beyond mechanisms KRAS-modulated cancer metabolisms remain incompletely understood. In this review, we aim to summarize current knowledge on KRAS-related alterations cells explore prevalence significance mutation shaping tumor microenvironment influencing epigenetic modification via various molecular activities. Given rely these changes sustain cell growth survival, targeting processes may represent a promising therapeutic strategy for KRAS-driven cancers.

Язык: Английский

Процитировано

4

Impact of cancer metabolism on therapy resistance – Clinical implications DOI Creative Commons
Ana Cristina Gonçalves, Elena Richiardone, Joana Jorge

и другие.

Drug Resistance Updates, Год журнала: 2021, Номер 59, С. 100797 - 100797

Опубликована: Дек. 1, 2021

Язык: Английский

Процитировано

89

Metabolism and polarization regulation of macrophages in the tumor microenvironment DOI
Jia Wang, Shichao Mi,

Muyao Ding

и другие.

Cancer Letters, Год журнала: 2022, Номер 543, С. 215766 - 215766

Опубликована: Июнь 8, 2022

Язык: Английский

Процитировано

53

Biomedical application of aggregation-induced emission luminogen-based fluorescent sensors DOI Creative Commons
Yanhong Duo,

Zhongyuan Xiang,

Ge Gao

и другие.

TrAC Trends in Analytical Chemistry, Год журнала: 2023, Номер 167, С. 117252 - 117252

Опубликована: Авг. 25, 2023

Fluorescent biosensors are powerful analytical tools that have been widely employed in a range of vitro and vivo biomedical applications. However, traditional fluorophores exhibit aggregation-caused quenching (ACQs) effects hinder their use the development more advanced fluorescent biosensors. The discovery by Prof. Ben Zhong Tang aggregation-induced emission (AIE) luminogen (AIEgen) opposite to those impacted ACQ provides unique opportunities for design novel "turn-on" These AIEgens thus attracted extensive interest from researchers seeking leverage properties produce effective biosensing molecules, strategies, associated A wide array with structures, functional groups, optical properties, applications developed recent years. In present review, we provide comprehensive overview advances field AIEgen-based biosensor discuss future clinical prospects these molecules. Through discussions, hope strong evidence-based foundation further efforts aimed at producing increasingly

Язык: Английский

Процитировано

26